International Biotechnology Trust’s Vir Biotechnology VIR Stock Holding History

International Biotechnology Trust’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$440K	Buy	+47,000	New	+$670K	0.15%	60

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

International Biotechnology Trust's VIR Position: Q3 2023 in Review

International Biotechnology Trust opened a new position in Vir Biotechnology (VIR) in Q3 2023: 47,000 shares worth $440K. The stake represents 0.15% of the portfolio and ranks #60 among its holdings.

214 funds tracked by Wall St. Rank hold VIR as of Q3 2023.

International Biotechnology Trust held 47,000 shares of Vir Biotechnology worth $440K as of Q3 2023.
Vir Biotechnology was a new International Biotechnology Trust position in Q3 2023.
Vir Biotechnology made up 0.15% of International Biotechnology Trust's portfolio in Q3 2023, its #60 holding.
214 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.